Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 63.10%2.71M | 63.10%2.71M | -84.43%1.66M | -84.43%1.66M | 49.66%10.69M | 49.66%10.69M | 23.67%7.14M | 23.67%7.14M | -31.92%5.78M | -31.92%5.78M |
| -Cash and cash equivalents | 63.10%2.71M | 63.10%2.71M | -84.43%1.66M | -84.43%1.66M | 49.66%10.69M | 49.66%10.69M | 23.67%7.14M | 23.67%7.14M | -31.92%5.78M | -31.92%5.78M |
| Securities and investments | -49.16%40.96M | -49.16%40.96M | 23.35%80.57M | 23.35%80.57M | 102.34%65.32M | 102.34%65.32M | -16.70%32.28M | -16.70%32.28M | -35.94%38.75M | -35.94%38.75M |
| -Trading securities | ---- | ---- | 23.35%40.28M | 23.35%40.28M | --32.66M | --32.66M | ---- | ---- | ---- | ---- |
| -Short term investments | 1.67%40.96M | 1.67%40.96M | 23.35%40.28M | 23.35%40.28M | 1.17%32.66M | 1.17%32.66M | -16.70%32.28M | -16.70%32.28M | 26.64%38.75M | 26.64%38.75M |
| Receivables | 129.02%513K | 129.02%513K | 190.91%224K | 190.91%224K | -60.10%77K | -60.10%77K | -81.84%193K | -81.84%193K | 164.43%1.06M | 164.43%1.06M |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | -81.84%193K | -81.84%193K | 261.56%1.06M | 261.56%1.06M |
| -Other receivables | 129.02%513K | 129.02%513K | 190.91%224K | 190.91%224K | --77K | --77K | ---- | ---- | ---- | ---- |
| Other assets | ---- | ---- | ---- | ---- | ---- | ---- | 12.50%36K | 12.50%36K | 23.08%32K | 23.08%32K |
| Total assets | -46.42%44.18M | -46.42%44.18M | 8.38%82.46M | 8.38%82.46M | 91.87%76.08M | 91.87%76.08M | -13.08%39.65M | -13.08%39.65M | -34.27%45.62M | -34.27%45.62M |
| Liabilities | ||||||||||
| Payables | 197.88%843K | 197.88%843K | -71.41%283K | -71.41%283K | 62.83%990K | 62.83%990K | -46.85%608K | -46.85%608K | -54.66%1.14M | -54.66%1.14M |
| -Accounts payable | 197.88%843K | 197.88%843K | -71.41%283K | -71.41%283K | 62.83%990K | 62.83%990K | -46.85%608K | -46.85%608K | -54.66%1.14M | -54.66%1.14M |
| Current deferred liabilities | ---- | ---- | -148.09%-176K | -148.09%-176K | 24.91%366K | 24.91%366K | -81.53%293K | -81.53%293K | --1.59M | --1.59M |
| Non current deferred liabilities | 82.69%1.47M | 82.69%1.47M | 94.43%803K | 94.43%803K | 175.33%413K | 175.33%413K | -90.41%150K | -90.41%150K | 1,718.60%1.56M | 1,718.60%1.56M |
| Other liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20K | --20K |
| Total liabilities | 153.85%2.31M | 153.85%2.31M | -48.56%910K | -48.56%910K | 68.32%1.77M | 68.32%1.77M | -75.64%1.05M | -75.64%1.05M | 65.35%4.31M | 65.35%4.31M |
| Shareholders'equity | ||||||||||
| Share capital | -4.30%31.67M | -4.30%31.67M | -5.15%33.09M | -5.15%33.09M | -1.73%34.89M | -1.73%34.89M | -4.65%35.5M | -4.65%35.5M | -6.06%37.23M | -6.06%37.23M |
| -common stock | -4.30%31.67M | -4.30%31.67M | -5.15%33.09M | -5.15%33.09M | -1.73%34.89M | -1.73%34.89M | -4.65%35.5M | -4.65%35.5M | -6.06%37.23M | -6.06%37.23M |
| Gains losses not affecting retained earnings | 24.90%10.2M | 24.90%10.2M | 20.74%8.17M | 20.74%8.17M | 118.40%6.77M | 118.40%6.77M | -23.96%3.1M | -23.96%3.1M | 100.79%4.07M | 100.79%4.07M |
| Total stockholders'equity | 1.48%41.87M | 1.48%41.87M | -0.94%41.26M | -0.94%41.26M | 7.91%41.66M | 7.91%41.66M | -6.55%38.6M | -6.55%38.6M | 12.27%41.31M | 12.27%41.31M |
| Total equity | 1.48%41.87M | 1.48%41.87M | -0.94%41.26M | -0.94%41.26M | 7.91%41.66M | 7.91%41.66M | -6.55%38.6M | -6.55%38.6M | 12.27%41.31M | 12.27%41.31M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |